Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes

被引:73
作者
Birchall, JC [1 ]
Kellaway, IW
Mills, SN
机构
[1] Univ Wales Coll Cardiff, Welsh Sch Pharm, Cardiff CF1 3XF, S Glam, Wales
[2] Glaxo Wellcome PLC, Ware SG12 0DP, Herts, England
关键词
cationic liposome; gene therapy; physico-chemical characterisation; transfection; DNA;
D O I
10.1016/S0378-5173(99)00117-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cationic liposomes spontaneously interact with negatively charged plasmid DNA to form a transfection competent complex capable of promoting the expression of a therapeutic gene. This work aims to improve the understanding of the poorly defined mechanisms and structural rearrangements associated with the lipid-DNA interaction. Specifically, dimethyl dioctadecylammonium bromide (DDAB):dioleoyl phosphatidylethanolaIninc (DOPE) and 1,2-dioleoyl-3-trimsthylammonium propane (DOTAP) liposomes were mixed with a reporter plasmid (pAD beta or pCMV beta) to form lipid-DNA complexes. The size and charge characteristics of the complexes as determined by photon correlation spectroscopy and microelectrophoresis were found to be dependent on the lipid:DNA ratio, with both DDAB:DOPE-DNA and DOTAP-DNA complexes aggregating at around neutral zeta potential. Negative stain transmission electron microscopy demonstrated at least three distinct complex structures being formed at the same DOTAP:DNA ratio. We postulate that two of these aggregates art: structural moieties involved in the formation of the efficient transfection particle. Gel electrophoresis was used to determine the efficiency and extent of lipid-DNA complex formation. Results showed that only DOTAP liposomes were capable of preventing ethidium bromide intercalation with DNA and protecting the enclosed plasmid from nuclease digestion. When a range of lipid-DNA complexes were transfected into in vitro cell lines, the efficiency of reporter gene (beta-galactosidase) expression was found to depend on the type of liposome used in the complex, the ratio of lipid:DNA and the transfected cell line. Our results challenge the requirement for DOPE to be included in the formulation of cationic lipid vectors, especially in the case of DOTAP containing liposomes. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:195 / 207
页数:13
相关论文
共 37 条
[1]  
Brigham K. L., 1993, Journal of Liposome Research, V3, P31, DOI 10.3109/08982109309147442
[2]  
Crook K, 1996, GENE THER, V3, P834
[3]   Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro [J].
Duncan, JE ;
Whitsett, JA ;
Horowitz, AD .
HUMAN GENE THERAPY, 1997, 8 (04) :431-438
[4]   THE ROLE OF DIOLEOYL PHOSPHATIDYLETHANOLAMINE IN CATIONIC LIPOSOME-MEDIATED GENE-TRANSFER [J].
FARHOOD, H ;
SERBINA, N ;
HUANG, L .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1235 (02) :289-295
[5]   Effect of co-lipids in enhancing cationic lipid-mediated gene transfer in vitro and in vivo [J].
Fasbender, A ;
Marshall, J ;
Moninger, TO ;
Grunst, T ;
Cheng, S ;
Welsh, MJ .
GENE THERAPY, 1997, 4 (07) :716-725
[6]   Improved cationic lipid formulations for in vivo gene therapy [J].
Felgner, PL ;
Tsai, YJ ;
Sukhu, L ;
Wheeler, CJ ;
Manthorpe, M ;
Marshall, J ;
Cheng, SH .
DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 :126-139
[7]   LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE [J].
FELGNER, PL ;
GADEK, TR ;
HOLM, M ;
ROMAN, R ;
CHAN, HW ;
WENZ, M ;
NORTHROP, JP ;
RINGOLD, GM ;
DANIELSEN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) :7413-7417
[8]  
Gao X, 1995, GENE THER, V2, P710
[9]   MODE OF FORMATION AND STRUCTURAL FEATURES OF DNA CATIONIC LIPOSOME COMPLEXES USED FOR TRANSFECTION [J].
GERSHON, H ;
GHIRLANDO, R ;
GUTTMAN, SB ;
MINSKY, A .
BIOCHEMISTRY, 1993, 32 (28) :7143-7151
[10]   COMPLEXES BETWEEN CATIONIC LIPOSOMES AND DNA VISUALIZED BY CRYO-TEM [J].
GUSTAFSSON, J ;
ARVIDSON, G ;
KARLSSON, G ;
ALMGREN, M .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1235 (02) :305-312